Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rui, Mizumoto"'
Autor:
Ryohei Yamauchi, Norio Hayashi, Shogo Nagahama, Takahiro Suda, Michiko Yoshimura, Koji Sunaga, Takayuki Iwamoto, Aya Yamamoto, Teruaki Nagano, Ryota Nakanishi, Yasutoshi Nozaki, Hiroko Hukusima, Hideki Hagiwara, Takashi Ohta, Michihito Toda, Shunsuke Tsuji, Yuki Arimoto, Shinjiro Yamaguchi, Takashi Iwata, Yoshiko Sudo, Jyongon Paku, Yoshiki Ito, Rui Mizumoto, Sho Yamaoka
Publikováno v:
Kanzo. 61:572-581
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21c8465ca14339db3299281b3adb5bac
https://doi.org/10.2957/kanzo.61.572
https://doi.org/10.2957/kanzo.61.572
Autor:
Takafumi, Mie, Takashi, Ohta, Takayuki, Iwamoto, Rui, Mizumoto, Yuki, Arimoto, Mayura, Toda, Satoshi, Shimizu, Shinjiro, Yamaguchi, Yoshiki, Ito, Hideki, Hagiwara
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 116(8)
A 42-year-old female developed type 1 diabetes mellitus at the age of 16 years and received insulin therapy. Esophagogastroduodenoscopy revealed an atrophic change localized in the gastric body and a small, protruding gastric lesion. Biopsy revealed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::febe1d270e0c290dca788298477ba311
https://pubmed.ncbi.nlm.nih.gov/31406070
https://pubmed.ncbi.nlm.nih.gov/31406070
Autor:
Yuki Makino, Rui Mizumoto, Nobuyuki Kajiwara, Tetsuo Takehara, Masanori Nakahara, Yoshiyuki Sawai, Tsugiko Oze, Norio Hayashi, Naoki Hiramatsu, Sinichiro Zushi, Sachiyo Kogita, Keiko Irishio, Sumio Kawata, Yasuharu Imai, Takumi Igura, Kazuto Fukuda, Yasushi Matsumoto
Publikováno v:
Hepatology Research. 44:1165-1171
Aim Renal damage has been reported as an important complication during combination treatment of peginterferon (PEG IFN), ribavirin (RBV) and telaprevir (TVR) for chronic hepatitis C. However, very little is known about this complication. We investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d91046eb6dd91be087621c2fbcae26f7
https://doi.org/10.1111/hepr.12229
https://doi.org/10.1111/hepr.12229
Autor:
Kazuto, Fukuda, Yasuharu, Imai, Naoki, Hiramatsu, Keiko, Irishio, Takumi, Igura, Yoshiyuki, Sawai, Sachiyo, Kogita, Yuki, Makino, Rui, Mizumoto, Yasushi, Matsumoto, Masanori, Nakahara, Sinichiro, Zushi, Nobuyuki, Kajiwara, Tsugiko, Oze, Sumio, Kawata, Norio, Hayashi, Tetsuo, Takehara
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 44(12)
Renal damage has been reported as an important complication during combination treatment of peginterferon (PEG IFN), ribavirin (RBV) and telaprevir (TVR) for chronic hepatitis C. However, very little is known about this complication. We investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4b63636985272f023b407c73d0a882d
https://pubmed.ncbi.nlm.nih.gov/24033816
https://pubmed.ncbi.nlm.nih.gov/24033816